By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Pernix Therapeutics, Inc. 

P.O. Box 40

Gonzales  Louisiana  70707-0040  U.S.A.
Phone: 800-793-2145 Fax:



Company News
Pernix (PTX) To Report Second Quarter 2015 Financial Results On Thursday, August 6, 2015 7/27/2015 7:48:52 AM
Pernix (PTX) Releases Positive In Vitro Abuse Deterrent Data For Third Generation Extended Release Hydrocodone ZX007 7/27/2015 7:22:07 AM
Pernix (PTX) To Present At JMP Securities Life Sciences Conference 6/16/2015 10:41:23 AM
Pernix (PTX) To Present At Jefferies and Co. 2015 Healthcare Conference 5/21/2015 11:51:10 AM
Pernix (PTX) Release: FDA Approves TREXIMET (Sumatriptan And Naproxen Sodium) For Use In Pediatric Patients 5/15/2015 9:21:44 AM
Pernix (PTX) Releases Pharmacokinetic Data For ZX007 5/5/2015 8:55:29 AM
Pernix (PTX) Launches Zohydro ER With BeadTek 5/4/2015 11:31:29 AM
Pernix (PTX) Reports First Quarter 2015 Financial Results 5/1/2015 10:38:49 AM
Pernix (PTX) Closes Acquisition Of Zohydro ER Franchise 4/27/2015 10:28:37 AM
Zogenix (ZGNX) Closes Sale Of Zohydro ER Business To Pernix (PTX) 4/24/2015 1:22:05 PM